JM
Jean-Francois Millithaler
cond-mat.softcond-mat.mes-hallphysics.bio-phphysics.chem-phq-bio.QMAptamersAptamers, Nucleotidecond-mat.stat-mechDrug Designeffective affinity
On Valency
published · living versionsW_e5k4eysc·v1 · currentpublished
Human olfactory receptor 17-40 as active part of a nanobiosensor: A microscopic investigation of its electrical properties
with Eleonora Alfinito, Lino Reggiani, Nadia Zine, Nicole Jaffrezic-Renault
1 version
Preprints & journals
7 papers in the corpus · 2011–2020Aptamers Which Target Proteins: What Proteotronics Suggests to Pharmaceutics.31942851 · Cataldo, Rosella, De Nunzio, Giorgio, Millithaler, Jean-Francois et al.2020 · 7 citationsCurrent pharmaceutical design. 2020;26(3):363-371
Charge transport in purple membrane monolayers: A sequential tunneling approach1105.0816v1 · Eleonora Alfinito, Jean-Francois Millithaler, Lino Reggiani2011 · 23 citationsPhysical Review E, 83, 042902 (2011)
Microscopic modeling of charge transport in sensing proteins.22726939 · Reggiani, Lino, Millithaler, Jean-Francois, Pennetta, Cecilia2012 · 3 citationsNanoscale research letters. 2012;7(1):340
Gumbel distribution and current fluctuations in critical systems1204.3411v1 · E. Alfinito, J. F. Millithaler, L. Reggiani2012 · 7 citationsarXiv
Charge transport in purple membrane monolayers: a sequential tunneling approach.21599225 · Alfinito, E, Millithaler, J-F, Reggiani, L2011 · 23 citationsPhysical review. E, Statistical, nonlinear, and soft matter physics. 2011;83(4 Pt 1):042902
Human olfactory receptor 17-40 as active part of a nanobiosensor: A microscopic investigation of its electrical properties1107.2778v1 · Eleonora Alfinito, Jean-Francois Millithaler, Lino Reggiani et al.2011 · 28 citationsRCS Advances 2011on Valency
Charge transport and current fluctuations in bacteriorhodopsin based nanodevices1102.3324v1 · J.-F. Millithaler, E. Alfinito, L. Reggiani2011 · 2 citationsarXiv
Career total: 60 works. 7 are in this corpus.
Profile built from the corpus for this byline.
Author records are still filling in while the Hub is in alpha. If this is your page, you'll be able to claim it soon. Spot a mistake? Tell us.